Todd Hornsby - 26 Jun 2023 Form 4/A - Amendment Insider Report for Apyx Medical Corp (APYX)

Signature
Todd Hornsby
Issuer symbol
APYX
Transactions as of
26 Jun 2023
Net transactions value
-$86,850
Form type
4/A - Amendment
Filing time
29 Jun 2023, 16:42:04 UTC
Date Of Original Report
28 Jun 2023
Previous filing
13 Jan 2023
Next filing
11 Jan 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APYX Common Stock Options Exercise $26,550 +15,000 $1.77 15,000 26 Jun 2023 Direct
transaction APYX Common Stock Sale $113,400 -15,000 -100% $7.56 0 26 Jun 2023 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APYX Stock Option (Option to Buy) Options Exercise $0 -15,000 -43% $0.000000 20,000 26 Jun 2023 Common Stock 15,000 $1.77 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The reported sale occurred automatically pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on March 21, 2023
F2 This transaction was executed in multiple trades at prices ranging from $7.30 to $7.70. The reported price in Column 4 is a weighted average price, rounded to the nearest hundredth. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F3 The original Form 4 is hereby amended to correct the amount of securities beneficially owned by the Reporting Person (as set forth in Column 5 of Table I) following the previously reported transactions